MarketCapTrends
BGMS
Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ

Cyclacel Pharmaceuticals, Inc. Cash on Hand 2009–2025

Cyclacel Pharmaceuticals, Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Cyclacel Pharmaceuticals, Inc. cash on hand for the quarter ending December 31, 2025 were 3.5M, a 11.73% increase year-over-year.
  • Cyclacel Pharmaceuticals, Inc. cash on hand for 2025 were 3.5M, a 11.73% increase from 2024.
  • Cyclacel Pharmaceuticals, Inc. cash on hand for 2024 were 3.1M, a 7.13% decrease from 2023.
  • Cyclacel Pharmaceuticals, Inc. cash on hand for 2023 were 3.4M, a 81.59% decrease from 2022.
  • Cyclacel Pharmaceuticals, Inc. cash on hand for 2022 were 18.3M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Cyclacel Pharmaceuticals, Inc. Annual Cash on Hand (Millions of US $)
2025$4
2024$3
2023$3
2022$18
2021$37
2020$33
2018$18
2017$24
2016$17
2015$20
2014$24
2013$31
2012$16
2011$24
2010$29
Cyclacel Pharmaceuticals, Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$4
2024-12-31$3
2023-12-31$3
2022-12-31$18
2021-12-31$37
2020-12-31$33
2018-12-31$18
2017-12-31$24
2016-12-31$17
2015-12-31$20
2014-12-31$24
2013-12-31$31
2012-12-31$16
2011-12-31$24
2010-12-31$29

Cyclacel Pharmaceuticals, Inc. Cash on Hand — FAQ

Cyclacel Pharmaceuticals, Inc. (BGMS) cash on hand over the last 16 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BGMS's cash on hand history?

The chart and table above show Cyclacel Pharmaceuticals, Inc.'s cash on hand by year and by quarter, including the growth rate.